panel: alternative ipo strategies for cell and gene therapy companies
Published 3 years ago • 98 plays • Length 1:00:23Download video MP4
Download video MP3
Similar videos
-
1:00:23
panel: alternate ipo strategies fo cell and gene therapy companies
-
49:16
panel: the state of investment in cell and gene therapy
-
52:32
panel: when does investing in cell and gene therapy make business sense?
-
59:49
plenary session: gene therapy & gene-modified cell therapies
-
51:10
panel: cell and gene therapy portfolio strategies
-
55:19
panel: large cap cell & gene therapy strategies
-
54:19
panel: cell and gene therapy for neurological product indications
-
1:05:49
panel: cell and gene therapies for chronic conditions
-
59:51
panel: next generation cell and gene therapy in oncology
-
23:40
expediting the development of cell and gene therapy
-
1:00:33
panel: gene therapy: building the gene medicine pipeline through next generation technologies
-
44:30
panel: gene therapy manufacturing
-
59:51
panel: what cell & gene therapy investors are looking for now
-
53:42
panel: between two virtual ferns: building a successful regenerative medicine company
-
1:11:29
panel: acceptance and uptake of cell and gene therapies: lessons learned and future focus
-
53:56
panel: cell and gene therapies for ophthalmologic diseases
-
58:25
panel: current realities of make vs. buy for cell & gene therapy manufacturing
-
47:01
panel: optimization of gene therapies: consideration of platform technologies
-
41:38
panel: durable gmp compliance for cell and gene therapies